Aspen Aerogels Inc. (ASPN) Now Covered by Analysts at Craig Hallum
Craig Hallum assumed coverage on shares of Aspen Aerogels Inc. (NYSE:ASPN) in a research report report published on Tuesday morning. The brokerage issued a buy rating and a $10.00 price objective on the stock.
Several other research analysts have also issued reports on ASPN. Canaccord Genuity restated a buy rating on shares of Aspen Aerogels in a research report on Wednesday, June 22nd. Citigroup Inc. decreased their price target on shares of Aspen Aerogels from $6.50 to $6.00 and set a buy rating on the stock in a research report on Thursday, July 7th. Zacks Investment Research upgraded shares of Aspen Aerogels from a sell rating to a hold rating in a research report on Monday, July 11th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Aspen Aerogels from $8.00 to $7.00 and set an overweight rating on the stock in a research report on Friday, August 5th. Two investment analysts have rated the stock with a sell rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus target price of $7.70.
Aspen Aerogels (NYSE:ASPN) opened at 5.22 on Tuesday. Aspen Aerogels has a 12 month low of $3.38 and a 12 month high of $8.87. The company has a 50 day moving average price of $4.88 and a 200 day moving average price of $4.60. The stock’s market capitalization is $107.44 million.
Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.02. The firm had revenue of $27.70 million for the quarter, compared to analyst estimates of $30.99 million. Aspen Aerogels had a negative net margin of 3.14% and a negative return on equity of 3.35%. During the same quarter in the previous year, the business posted ($0.12) earnings per share. Equities research analysts predict that Aspen Aerogels will post ($0.30) earnings per share for the current year.
In other news, Director William P. Noglows acquired 20,000 shares of the stock in a transaction on Wednesday, August 24th. The shares were purchased at an average cost of $4.98 per share, for a total transaction of $99,600.00. Following the transaction, the director now owns 46,178 shares in the company, valued at approximately $229,966.44. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard F. Reilly acquired 10,000 shares of the stock in a transaction on Tuesday, August 23rd. The shares were purchased at an average price of $4.82 per share, for a total transaction of $48,200.00. Following the completion of the transaction, the director now owns 36,178 shares in the company, valued at approximately $174,377.96. The disclosure for this purchase can be found here. Company insiders own 14.70% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. purchased a new position in Aspen Aerogels during the first quarter valued at $115,000. Balter Liquid Alternatives LLC boosted its position in Aspen Aerogels by 162.8% in the first quarter. Balter Liquid Alternatives LLC now owns 33,236 shares of the company’s stock valued at $150,000 after buying an additional 20,590 shares during the last quarter. Firsthand Capital Management Inc. boosted its position in Aspen Aerogels by 16.7% in the second quarter. Firsthand Capital Management Inc. now owns 35,000 shares of the company’s stock valued at $174,000 after buying an additional 5,000 shares during the last quarter. GSA Capital Partners LLP boosted its position in Aspen Aerogels by 71.6% in the second quarter. GSA Capital Partners LLP now owns 44,129 shares of the company’s stock valued at $219,000 after buying an additional 18,419 shares during the last quarter. Finally, Palisade Capital Management LLC NJ purchased a new position in Aspen Aerogels during the first quarter valued at $221,000. Hedge funds and other institutional investors own 76.10% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.